260 related articles for article (PubMed ID: 17167727)
1. [Pathophysiological aspects of brain structural disturbances in patients with Fabry disease: literature review].
Nill M; Müller MJ; Beck M; Stoeter P; Fellgiebel A
Fortschr Neurol Psychiatr; 2006 Dec; 74(12):687-95. PubMed ID: 17167727
[TBL] [Abstract][Full Text] [Related]
2. Neurological complications of Anderson-Fabry disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Arnao V; Licata G; Pinto A
Curr Pharm Des; 2013; 19(33):6014-30. PubMed ID: 23448452
[TBL] [Abstract][Full Text] [Related]
3. Enzyme replacement therapy stabilized white matter lesion progression in Fabry disease.
Fellgiebel A; Gartenschläger M; Wildberger K; Scheurich A; Desnick RJ; Sims K
Cerebrovasc Dis; 2014; 38(6):448-56. PubMed ID: 25502511
[TBL] [Abstract][Full Text] [Related]
4. Anderson-Fabry disease: a multiorgan disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of different MRI and MR angiography measures in Fabry disease.
Fellgiebel A; Keller I; Marin D; Müller MJ; Schermuly I; Yakushev I; Albrecht J; Bellhäuser H; Kinateder M; Beck M; Stoeter P
Neurology; 2009 Jan; 72(1):63-8. PubMed ID: 19122032
[TBL] [Abstract][Full Text] [Related]
6. Development and clinical consequences of white matter lesions in Fabry disease: a systematic review.
Körver S; Vergouwe M; Hollak CEM; van Schaik IN; Langeveld M
Mol Genet Metab; 2018 Nov; 125(3):205-216. PubMed ID: 30213639
[TBL] [Abstract][Full Text] [Related]
7. Pattern of microstructural brain tissue alterations in Fabry disease: a diffusion-tensor imaging study.
Fellgiebel A; Mazanek M; Whybra C; Beck M; Hartung R; Müller KM; Scheurich A; Dellani PR; Stoeter P; Müller MJ
J Neurol; 2006 Jun; 253(6):780-7. PubMed ID: 16511647
[TBL] [Abstract][Full Text] [Related]
8. CNS manifestations of Fabry's disease.
Fellgiebel A; Müller MJ; Ginsberg L
Lancet Neurol; 2006 Sep; 5(9):791-5. PubMed ID: 16914407
[TBL] [Abstract][Full Text] [Related]
9. [Psychiatric and neuropsychological signs and symptoms in patients with fabry disease: literature review].
Müller MJ; Müller KM; Dascalescu A; Whybra C; Baron K; Scheurich A; Mann K; Beck M; Schmidt LG; Fellgiebel A
Fortschr Neurol Psychiatr; 2005 Nov; 73(11):687-93. PubMed ID: 16283613
[TBL] [Abstract][Full Text] [Related]
10. Voxel based analyses of diffusion tensor imaging in Fabry disease.
Albrecht J; Dellani PR; Müller MJ; Schermuly I; Beck M; Stoeter P; Gerhard A; Fellgiebel A
J Neurol Neurosurg Psychiatry; 2007 Sep; 78(9):964-9. PubMed ID: 17449543
[TBL] [Abstract][Full Text] [Related]
11. White matter lesion severity in male and female patients with Fabry disease.
Fellgiebel A; Müller MJ; Mazanek M; Baron K; Beck M; Stoeter P
Neurology; 2005 Aug; 65(4):600-2. PubMed ID: 16116124
[TBL] [Abstract][Full Text] [Related]
12. Quantification of brain tissue alterations in Fabry disease using diffusion-tensor imaging.
Fellgiebel A; Albrecht J; Dellani PR; Schermuly I; Stoeter P; Müller MJ
Acta Paediatr; 2007 Apr; 96(455):33-6. PubMed ID: 17391437
[TBL] [Abstract][Full Text] [Related]
13. The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women.
Gupta S; Ries M; Kotsopoulos S; Schiffmann R
Medicine (Baltimore); 2005 Sep; 84(5):261-268. PubMed ID: 16148726
[TBL] [Abstract][Full Text] [Related]
14. [Neurological aspects of Fabry's disease].
Clavelou P; Besson G; Elziere C; Ferrier A; Pinard JM; Hermier M; Artigou JY; Germain DP
Rev Neurol (Paris); 2006 May; 162(5):569-80. PubMed ID: 16710123
[TBL] [Abstract][Full Text] [Related]
15. Screening for health-related quality of life and its determinants in Fabry disease: A cross-sectional multicenter study.
Winter Y; Hilz M; Beuschlein F; Tsukimura T; Seifritz E; Lenders M; Brand E; Hennermann JB; Nowak A
Mol Genet Metab; 2023 Nov; 140(3):107692. PubMed ID: 37703724
[TBL] [Abstract][Full Text] [Related]
16. De novo Diagnosis of Fabry Disease among Italian Adults with Acute Ischemic Stroke or Transient Ischemic Attack.
Romani I; Borsini W; Nencini P; Morrone A; Ferri L; Frusconi S; Donadio VA; Liguori R; Donati MA; Falconi S; Pracucci G; Inzitari D
J Stroke Cerebrovasc Dis; 2015 Nov; 24(11):2588-95. PubMed ID: 26298600
[TBL] [Abstract][Full Text] [Related]
17. The heart in Fabry's disease.
Sheppard MN
Cardiovasc Pathol; 2011; 20(1):8-14. PubMed ID: 19919901
[TBL] [Abstract][Full Text] [Related]
18. Brain MRI findings in children and adolescents with Fabry disease.
Marchesoni C; Cisneros E; Pfister P; Yáñez P; Rollan C; Romero C; Kisinovsky I; Rattagan L; León Cejas L; Pardal A; Sevlever G; Reisin R
J Neurol Sci; 2018 Dec; 395():131-134. PubMed ID: 30316069
[TBL] [Abstract][Full Text] [Related]
19. Detection of blood Gb3 deposits as a new tool for diagnosis and therapy monitoring in patients with classic Fabry disease.
Üçeyler N; Böttger J; Henkel L; Langjahr M; Mayer C; Nordbeck P; Wanner C; Sommer C
J Intern Med; 2018 Oct; 284(4):427-438. PubMed ID: 29974530
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Fabry Disease in Young Patients with Stroke in Argentina.
Reisin RC; Mazziotti J; Cejas LL; Zinnerman A; Bonardo P; Pardal MF; Martínez A; Riccio P; Ameriso S; Bendersky E; Nofal P; Cairola P; Jure L; Sotelo A; Rozenfeld P; Ceci R; Casas-Parera I; Sánchez-Luceros A;
J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):575-582. PubMed ID: 29132836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
